The favorable cognitive profile of patients with an isocitrate dehydrogenase (IDH) 1 or 2 gene- mutated glioma is an example of this.15 Mutations in IDH 1 and 2 occur in the vast majority of low-grade gliomas and in secondary high-grade gliomas. This evidence concerns the gene IDH3A and central nervous system cancer.